These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30413420)

  • 1. Inhibitory killer cell immunoglobulin-like receptors strengthen CD8
    Boelen L; Debebe B; Silveira M; Salam A; Makinde J; Roberts CH; Wang ECY; Frater J; Gilmour J; Twigger K; Ladell K; Miners KL; Jayaraman J; Traherne JA; Price DA; Qi Y; Martin MP; Macallan DC; Thio CL; Astemborski J; Kirk G; Donfield SM; Buchbinder S; Khakoo SI; Goedert JJ; Trowsdale J; Carrington M; Kollnberger S; Asquith B
    Sci Immunol; 2018 Nov; 3(29):. PubMed ID: 30413420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection.
    Seich Al Basatena NK; Macnamara A; Vine AM; Thio CL; Astemborski J; Usuku K; Osame M; Kirk GD; Donfield SM; Goedert JJ; Bangham CR; Carrington M; Khakoo SI; Asquith B
    PLoS Pathog; 2011 Oct; 7(10):e1002270. PubMed ID: 22022261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.
    Tomescu C; Duh FM; Hoh R; Viviani A; Harvill K; Martin MP; Carrington M; Deeks SG; Montaner LJ
    AIDS; 2012 Sep; 26(15):1869-78. PubMed ID: 22874514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection.
    Alter G; Rihn S; Streeck H; Teigen N; Piechocka-Trocha A; Moss K; Cohen K; Meier A; Pereyra F; Walker B; Altfeld M
    J Virol; 2008 Oct; 82(19):9668-77. PubMed ID: 18579582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of killer cell immunoglobulin-like receptors (KIRs) in Korean patients with chronic HCV infection.
    Sung PS; Choi HB; Kim SY; Hong SW; Park CH; Song MJ; Lee SW; Yoo CR; Choi SW; Han NI; Kim TG; Yoon SK
    J Korean Med Sci; 2011 Nov; 26(11):1483-8. PubMed ID: 22065905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells.
    Björkström NK; Béziat V; Cichocki F; Liu LL; Levine J; Larsson S; Koup RA; Anderson SK; Ljunggren HG; Malmberg KJ
    Blood; 2012 Oct; 120(17):3455-65. PubMed ID: 22968455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use.
    Ruiz-Mateos E; Ruiz-León MJ; Tarancón-Díez L; Gutiérrez C; Dronda F; Domínguez-Molina B; Pérez-Elías MJ; Moreno A; Leal M; Moreno S; Vallejo A
    Virus Res; 2019 Apr; 264():40-44. PubMed ID: 30776394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.
    Kuśnierczyk P; Mozer-Lisewska I; Zwolińska K; Kowala-Piaskowska AE; Bura M; Bereszyńska I; Pauli A; Żeromski J
    Hum Immunol; 2015 Mar; 76(2-3):102-8. PubMed ID: 25636579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells.
    Anfossi N; Doisne JM; Peyrat MA; Ugolini S; Bonnaud O; Bossy D; Pitard V; Merville P; Moreau JF; Delfraissy JF; Dechanet-Merville J; Bonneville M; Venet A; Vivier E
    J Immunol; 2004 Dec; 173(12):7223-9. PubMed ID: 15585844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying the immune interactions underlying HLA class I disease associations.
    Debebe BJ; Boelen L; Lee JC; ; Thio CL; Astemborski J; Kirk G; Khakoo SI; Donfield SM; Goedert JJ; Asquith B
    Elife; 2020 Apr; 9():. PubMed ID: 32238263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
    J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 adaptation to NK-cell-mediated immune pressure.
    Alter G; Heckerman D; Schneidewind A; Fadda L; Kadie CM; Carlson JM; Oniangue-Ndza C; Martin M; Li B; Khakoo SI; Carrington M; Allen TM; Altfeld M
    Nature; 2011 Aug; 476(7358):96-100. PubMed ID: 21814282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of killer cell immunoglobulin-like receptors with spontaneous clearance of hepatitis C virus in the Chinese population.
    Shan Z; Huang J; Liao Q; Huang K; Wang M; Xu R; Tang X; Zhang W; Nelson K; Fu Y; Li C; Rong X
    Transfusion; 2018 Apr; 58(4):1028-1035. PubMed ID: 29446443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killer cell immunoglobulin-like receptor expression induction on neonatal CD8(+) T cells in vitro and following congenital infection with Trypanosoma cruzi.
    Hermann E; Berthe A; Truyens C; Alonso-Vega C; Parrado R; Torrico F; Carlier Y; Braud VM
    Immunology; 2010 Mar; 129(3):418-26. PubMed ID: 19922420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1.
    Kim AY; Lauer GM; Ouchi K; Addo MM; Lucas M; Schulze Zur Wiesch J; Timm J; Boczanowski M; Duncan JE; Wurcel AG; Casson D; Chung RT; Draenert R; Klenerman P; Walker BD
    Blood; 2005 Feb; 105(3):1170-8. PubMed ID: 15459014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions.
    Izaki M; Yasunaga JI; Nosaka K; Sugata K; Utsunomiya H; Suehiro Y; Shichijo T; Yamada A; Sugawara Y; Hibi T; Inomata Y; Akari H; Melamed A; Bangham C; Matsuoka M
    PLoS Pathog; 2021 Feb; 17(2):e1009271. PubMed ID: 33524072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIR
    Choi SJ; Koh JY; Rha MS; Seo IH; Lee H; Jeong S; Park SH; Shin EC
    Cell Rep; 2023 Mar; 42(3):112236. PubMed ID: 36897779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inability to detect human T cell lymphotropic virus type 2-specific antibodies in a patient coinfected with HIV-1, human T cell lymphotropic virus type 1, human T cell lymphotropic virus type 2, and hepatitis C virus.
    Caterino-de-Araujo A; Magri MC; Sato NS; Morimoto HK; Brigido LF; Morimoto AA
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):97-101. PubMed ID: 23875602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C.
    Vollmers S; Lobermeyer A; Niehrs A; Fittje P; Indenbirken D; Nakel J; Virdi S; Brias S; Trenkner T; Sauer G; Peine S; Behrens GMN; Lehmann C; Meurer A; Pauli R; Postel N; Roider J; Scholten S; Spinner CD; Stephan C; Wolf E; Wyen C; Richert L; Norman PJ; Sauter J; Schmidt AH; Hoelzemer A; Altfeld M; Körner C
    Front Immunol; 2022; 13():922252. PubMed ID: 35911762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.